Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Interest & Investment Income (2022 - 2026)

Journey Medical filings provide 4 years of Interest & Investment Income readings, the most recent being $148000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 22.51% to $148000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $589000.0, a 22.19% decrease, with the full-year FY2025 number at $589000.0, down 22.19% from a year prior.
  • Interest & Investment Income hit $148000.0 in Q4 2025 for Journey Medical, down from $154000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $217000.0 in Q1 2024 to a low of $3000.0 in Q1 2022.
  • Median Interest & Investment Income over the past 4 years was $130000.0 (2023), compared with a mean of $108000.0.
  • Biggest five-year swings in Interest & Investment Income: skyrocketed 3966.67% in 2023 and later crashed 31.34% in 2025.
  • Journey Medical's Interest & Investment Income stood at $50000.0 in 2022, then soared by 126.0% to $113000.0 in 2023, then surged by 69.03% to $191000.0 in 2024, then dropped by 22.51% to $148000.0 in 2025.
  • The last three reported values for Interest & Investment Income were $148000.0 (Q4 2025), $154000.0 (Q3 2025), and $138000.0 (Q2 2025) per Business Quant data.